Loading oncology approvals…
Loading oncology approvals…
Regulatory
Every record is one authority's decision for one application or DIN, shown with its jurisdiction, date, indication text as published and status. A molecule approved in one jurisdiction for one indication is not 'approved' in general.
RegulatoryDevelopment pipeline →Methodology
Coverage
Counts of records, not of drugs approved: one application can carry several dated records (original approval, efficacy supplements, one row per DIN in Canada).
Approval records
4,342
Distinct drugs
373
Records naming a cancer
982
Dated in the last 12 months
179
| Authority | Jurisdiction | Records | Drugs | In force | Withdrawn / cancelled | Last 12 months | Latest dated record |
|---|---|---|---|---|---|---|---|
| FDA | US | 2,343 | 304 | 2,343 | 0 | 115 | Sep 18, 2026 |
| Health Canada | CA | 1,538 | 273 | 979 | 559 | 44 | Sep 22, 2026 |
| EMA | EU | 461 | 246 | 386 | 75 | 20 | Sep 18, 2026 |
Data updated yesterdaySource updated unknown3 authority · jurisdiction pairs ingested
Feed
Latest approval date first; records without a date are listed last. Filters combine.
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1983 | Amsacrine | Health Canada CA | cancer not stated in this record | Marketed in Canada as AMSA PD (DIN 00582212) under ATC L01XX01 AMSACRINE. Indications are not published in the Drug Product Database — see… | DIN00582212 | withdrawnsource: Cancelled Post Marketsince Jul 18, 2024 | health-canada-dpd |
| Dec 31, 1983 | Aminoglutethimide | Health Canada CA | cancer not stated in this record | Marketed in Canada as CYTADREN TAB 250MG (DIN 00587729) under ATC L02BG01 AMINOGLUTHETIMIDE. Indications are not published in the Drug… | DIN00587729 | withdrawnsource: Cancelled Post Marketsince Aug 4, 1999 | health-canada-dpd |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1982 | Vindesine | Health Canada CA | cancer not stated in this record | Marketed in Canada as ELDISINE INJ 5MG/2ML (DIN 00555665) under ATC L01CA03 VINDESINE. Indications are not published in the Drug Product… | DIN00555665 |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1981 | Etoposide | Health Canada CA | cancer not stated in this record | Marketed in Canada as VEPESID INJ 20MG/ML (DIN 00523410) under ATC L01CB01 ETOPOSIDE. Indications are not published in the Drug Product… | DIN00523410 |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1979 | Hydroxyurea | Health Canada CA | cancer not stated in this record | Marketed in Canada as HYDREA (DIN 00465283) under ATC L01XX05 HYDROXYCARBAMIDE. Indications are not published in the Drug Product Database… | DIN00465283 |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1978 | Fluorouracil | Health Canada CA | cancer not stated in this record | Marketed in Canada as ADRUCIL INJ 50MG/ML (DIN 00428493) under ATC L01BC02 FLUOROURACIL. Indications are not published in the Drug Product… | DIN |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1977 | Methotrexate | Health Canada CA | cancer not stated in this record | Marketed in Canada as METHOTREXATE SODIUM INJ 20MG (DIN 00410195) under ATC L01BA01 METHOTREXATE. Indications are not published in the Drug… | DIN |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1976 | Dacarbazine | Health Canada CA | cancer not stated in this record | Marketed in Canada as DTIC DOME INJ 200MG/VIAL (DIN 00521183) under ATC L01AX04 DACARBAZINE. Indications are not published in the Drug… | DIN00521183 |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1975 | Carmustine | Health Canada CA | cancer not stated in this record | Marketed in Canada as BICNU (DIN 00297763) under ATC L01AD01 CARMUSTINE. Indications are not published in the Drug Product Database — see… | DIN00297763 |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1974 | Asparaginase | Health Canada CA | cancer not stated in this record | Marketed in Canada as KIDROLASE (DIN 01926438) under ATC L01XX02 ASPARAGINASE. Indications are not published in the Drug Product Database —… | DIN01926438 |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1973 | Cyclophosphamide | Health Canada CA | cancer not stated in this record | Marketed in Canada as PROCYTOX TAB 25MG (DIN 00262676) under ATC L01AA01 CYCLOPHOSPHAMIDE. Indications are not published in the Drug… | DIN |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1971 | Daunorubicin | Health Canada CA | cancer not stated in this record | Marketed in Canada as CERUBIDINE (DIN 01926683) under ATC L01DB02 DAUNORUBICIN. Indications are not published in the Drug Product Database… | DIN01926683 |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1970 | Procarbazine | Health Canada CA | cancer not stated in this record | Marketed in Canada as MATULANE (DIN 00012750) under ATC L01XB01 PROCARBAZINE. Indications are not published in the Drug Product Database —… | DIN00012750 |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1966 | Cyclophosphamide | Health Canada CA | cancer not stated in this record | Marketed in Canada as PROCYTOX VIAL 1000MG (DIN 00013552) under ATC L01AA01 CYCLOPHOSPHAMIDE. Indications are not published in the Drug… | DIN |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1964 | Melphalan | Health Canada CA | cancer not stated in this record | Marketed in Canada as ALKERAN (DIN 00004715) under ATC L01AA03 MELPHALAN. Indications are not published in the Drug Product Database — see… | DIN00004715 |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1963 | Dactinomycin | Health Canada CA | cancer not stated in this record | Marketed in Canada as COSMEGEN (DIN 00213071) under ATC L01DA01 DACTINOMYCIN. Indications are not published in the Drug Product Database —… | DIN00213071 |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1959 | Thiotepa | Health Canada CA | cancer not stated in this record | Marketed in Canada as THIO TEPA INJ 15MG/VIAL (DIN 00237035) under ATC L01AC01 THIOTEPA. Indications are not published in the Drug Product… | DIN00237035 |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1958 | Diethylstilbestrol | Health Canada CA | cancer not stated in this record | Marketed in Canada as HONVOL TABLETS 100MG (DIN 00013781) under ATC L02AA01 DIETHYLSTILBESTROL. Indications are not published in the Drug… | DIN |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1957 | Chlorambucil | Health Canada CA | cancer not stated in this record | Marketed in Canada as LEUKERAN (DIN 00004626) under ATC L01AA02 CHLORAMBUCIL. Indications are not published in the Drug Product Database —… | DIN00004626 |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1956 | Diethylstilbestrol | Health Canada CA | cancer not stated in this record | Marketed in Canada as HONVOL AMPOULES 250MG (DIN 00013587) under ATC L02AA01 DIETHYLSTILBESTROL. Indications are not published in the Drug… | DIN |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1955 | Methotrexate | Health Canada CA | cancer not stated in this record | Marketed in Canada as METHOTREXATE TAB 2.5MG (DIN 00014915) under ATC L01BA01 METHOTREXATE. Indications are not published in the Drug… | DIN00014915 |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1954 | Mercaptopurine | Health Canada CA | cancer not stated in this record | Marketed in Canada as PURINETHOL (DIN 00004723) under ATC L01BB02 MERCAPTOPURINE. Indications are not published in the Drug Product… | DIN00004723 |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| Dec 31, 1951 | Mechlorethamine | Health Canada CA | cancer not stated in this record | Marketed in Canada as MUSTARGEN (DIN 00016063) under ATC L01AA05 CHLORMETHINE. Indications are not published in the Drug Product Database —… | DIN00016063 |
| Date | Drug | Authority · jurisdiction | Cancer | Indication (as published) | Type | Status | Source |
|---|---|---|---|---|---|---|---|
| — | Isatuximab | Health Canada CA | cancer not stated in this record | Marketed in Canada as SARCLISA SC (DIN 02571498) under ATC L01FC02 ISATUXIMAB. Indications are not published in the Drug Product Database —… | DIN02571498 |
A record is one authority's decision for one application/DIN; the same molecule appears once per jurisdiction and indication. Health Canada DPD does not publish indications — its records state the brand, DIN and ATC class only, and a cancelled or dormant DIN is the status of one product, not of the molecule. FDA cancer mappings come from label text and are flagged probabilistic on the drug page.
| withdrawnsource: Cancelled Post Marketsince Aug 3, 2000 |
| health-canada-dpd |
| withdrawnsource: Cancelled Post Marketsince Oct 30, 2007 |
| health-canada-dpd |
| Dec 31, 1981 | Methotrexate | Health Canada CA | cancer not stated in this record | Marketed in Canada as METHOTREXATE SODIUM INJ 25MG/ML (DIN 00519286) under ATC L01BA01 METHOTREXATE. Indications are not published in the… | DIN00519286 | withdrawnsource: Cancelled Post Marketsince Aug 14, 1997 | health-canada-dpd |
| approvedsource: Marketed |
| health-canada-dpd |
| Dec 31, 1979 | Mitotane | Health Canada CA | cancer not stated in this record | Marketed in Canada as LYSODREN (DIN 00463221) under ATC L01XX23 MITOTANE. Indications are not published in the Drug Product Database — see… | DIN00463221 | approvedsource: Marketed | health-canada-dpd |
| withdrawnsource: Cancelled Post Marketsince Sep 10, 1996 |
| health-canada-dpd |
| withdrawnsource: Cancelled Post Marketsince Aug 14, 1997 |
| health-canada-dpd |
| Dec 31, 1977 | Cyclophosphamide | Health Canada CA | cancer not stated in this record | Marketed in Canada as PROCYTOX PWS 500MG (DIN 00373753) under ATC L01AA01 CYCLOPHOSPHAMIDE. Indications are not published in the Drug… | DIN00373753 | withdrawnsource: Cancelled Post Marketsince Nov 17, 2000 | health-canada-dpd |
| Dec 31, 1977 | Cytarabine | Health Canada CA | cancer not stated in this record | Marketed in Canada as CYTOSAR (DIN 00194727) under ATC L01BC01 CYTARABINE. Indications are not published in the Drug Product Database — see… | DIN00194727 | withdrawnsource: Cancelled Post Marketsince Jul 4, 2025 | health-canada-dpd |
| Dec 31, 1977 | Cytarabine | Health Canada CA | cancer not stated in this record | Marketed in Canada as CYTOSAR (DIN 00386715) under ATC L01BC01 CYTARABINE. Indications are not published in the Drug Product Database — see… | DIN00386715 | withdrawnsource: Cancelled Post Marketsince Jul 4, 2025 | health-canada-dpd |
| Dec 31, 1977 | Megestrol | Health Canada CA | cancer not stated in this record | Marketed in Canada as MEGACE (DIN 00386391) under ATC L02AB01 MEGESTROL. Indications are not published in the Drug Product Database — see… | DIN00386391 | withdrawnsource: Cancelled Post Marketsince May 29, 2006 | health-canada-dpd |
| Dec 31, 1977 | Cyclophosphamide | Health Canada CA | cancer not stated in this record | Marketed in Canada as CYTOXAN TAB 25MG (DIN 00344877) under ATC L01AA01 CYCLOPHOSPHAMIDE. Indications are not published in the Drug Product… | DIN00344877 | withdrawnsource: Cancelled Post Marketsince Nov 21, 2008 | health-canada-dpd |
| Dec 31, 1977 | Mitomycin | Health Canada CA | cancer not stated in this record | Marketed in Canada as MUTAMYCIN INJ 5MG/VIAL (DIN 00381799) under ATC L01DC03 MITOMYCIN. Indications are not published in the Drug Product… | DIN00381799 | withdrawnsource: Cancelled Post Marketsince May 29, 2006 | health-canada-dpd |
| withdrawnsource: Cancelled Post Marketsince Sep 25, 1998 |
| health-canada-dpd |
| Dec 31, 1976 | Lomustine | Health Canada CA | cancer not stated in this record | Marketed in Canada as CEENU (DIN 00360430) under ATC L01AD02 LOMUSTINE. Indications are not published in the Drug Product Database — see… | DIN00360430 | approvedsource: Marketed | health-canada-dpd |
| Dec 31, 1976 | Lomustine | Health Canada CA | cancer not stated in this record | Marketed in Canada as CEENU (DIN 00360422) under ATC L01AD02 LOMUSTINE. Indications are not published in the Drug Product Database — see… | DIN00360422 | approvedsource: Marketed | health-canada-dpd |
| Dec 31, 1976 | Lomustine | Health Canada CA | cancer not stated in this record | Marketed in Canada as CEENU (DIN 00360414) under ATC L01AD02 LOMUSTINE. Indications are not published in the Drug Product Database — see… | DIN00360414 | withdrawnsource: Cancelled Post Marketsince Oct 1, 2019 | health-canada-dpd |
| Dec 31, 1976 | Doxorubicin | Health Canada CA | cancer not stated in this record | Marketed in Canada as ADRIAMYCIN RDF INJ 10MG/VIAL (DIN 00357391) under ATC L01DB01 DOXORUBICIN. Indications are not published in the Drug… | DIN00357391 | withdrawnsource: Cancelled Post Marketsince Sep 10, 1996 | health-canada-dpd |
| Dec 31, 1976 | Doxorubicin | Health Canada CA | cancer not stated in this record | Marketed in Canada as ADRIAMYCIN RDF INJ 50MG/VIAL (DIN 00353078) under ATC L01DB01 DOXORUBICIN. Indications are not published in the Drug… | DIN00353078 | withdrawnsource: Cancelled Post Marketsince Sep 10, 1996 | health-canada-dpd |
| Dec 31, 1976 | Methotrexate | Health Canada CA | cancer not stated in this record | Marketed in Canada as METHOTREXATE SODIUM INJ 25.0MG/ML (DIN 00321397) under ATC L01BA01 METHOTREXATE. Indications are not published in the… | DIN00321397 | withdrawnsource: Cancelled Post Marketsince Aug 14, 1997 | health-canada-dpd |
| Dec 31, 1976 | Cyclophosphamide | Health Canada CA | cancer not stated in this record | Marketed in Canada as CYTOXAN TAB 50MG (DIN 00344885) under ATC L01AA01 CYCLOPHOSPHAMIDE. Indications are not published in the Drug Product… | DIN00344885 | withdrawnsource: Cancelled Post Marketsince Jan 22, 2009 | health-canada-dpd |
| approvedsource: Marketed |
| health-canada-dpd |
| Dec 31, 1975 | Fluorouracil | Health Canada CA | cancer not stated in this record | Marketed in Canada as EFUDEX (DIN 00330582) under ATC L01BC02 FLUOROURACIL. Indications are not published in the Drug Product Database —… | DIN00330582 | approvedsource: Marketed | health-canada-dpd |
| withdrawnsource: Cancelled Post Marketsince Jul 7, 2021 |
| health-canada-dpd |
| Dec 31, 1974 | Thioguanine | Health Canada CA | cancer not stated in this record | Marketed in Canada as LANVIS (DIN 00282081) under ATC L01BB03 TIOGUANINE. Indications are not published in the Drug Product Database — see… | DIN00282081 | approvedsource: Marketed | health-canada-dpd |
| withdrawnsource: Cancelled Post Marketsince May 22, 2001 |
| health-canada-dpd |
| Dec 31, 1973 | Bleomycin | Health Canada CA | cancer not stated in this record | Marketed in Canada as BLENOXANE PWS 15UNIT (DIN 00258482) under ATC L01DC01 BLEOMYCIN. Indications are not published in the Drug Product… | DIN00258482 | withdrawnsource: Cancelled Post Marketsince Oct 19, 2011 | health-canada-dpd |
| approvedsource: Marketed |
| health-canada-dpd |
| approvedsource: Marketed |
| health-canada-dpd |
| withdrawnsource: Cancelled Post Marketsince May 22, 2001 |
| health-canada-dpd |
| approvedsource: Marketed |
| health-canada-dpd |
| approvedsource: Marketed |
| health-canada-dpd |
| withdrawnsource: Cancelled Post Marketsince Nov 24, 1997 |
| health-canada-dpd |
| Dec 31, 1959 | Cyclophosphamide | Health Canada CA | cancer not stated in this record | Marketed in Canada as PROCYTOX VIAL 200MG (DIN 00013544) under ATC L01AA01 CYCLOPHOSPHAMIDE. Indications are not published in the Drug… | DIN00013544 | withdrawnsource: Cancelled Post Marketsince Nov 26, 2000 | health-canada-dpd |
| Dec 31, 1959 | Cyclophosphamide | Health Canada CA | cancer not stated in this record | Marketed in Canada as PROCYTOX TABLETS 50MG (DIN 00013749) under ATC L01AA01 CYCLOPHOSPHAMIDE. Indications are not published in the Drug… | DIN00013749 | withdrawnsource: Cancelled Post Marketsince May 22, 2001 | health-canada-dpd |
| withdrawnsource: Cancelled Post Marketsince May 22, 2001 |
| health-canada-dpd |
| approvedsource: Marketed |
| health-canada-dpd |
| withdrawnsource: Cancelled Post Marketsince Nov 17, 2000 |
| health-canada-dpd |
| withdrawnsource: Cancelled Post Marketsince Aug 14, 1997 |
| health-canada-dpd |
| approvedsource: Marketed |
| health-canada-dpd |
| Dec 31, 1954 | Busulfan | Health Canada CA | cancer not stated in this record | Marketed in Canada as MYLERAN (DIN 00004618) under ATC L01AB01 BUSULFAN. Indications are not published in the Drug Product Database — see… | DIN00004618 | approvedsource: Marketed | health-canada-dpd |
| withdrawnsource: Cancelled Post Marketsince Nov 11, 2011 |
| health-canada-dpd |
| approved |
| health-canada-dpd |
| — | Abiraterone Acetate | Health Canada CA | cancer not stated in this record | Marketed in Canada as MINT-ABIRATERONE (DIN 02571447) under ATC L02BX03 ABIRATERONE. Indications are not published in the Drug Product… | DIN02571447 | approved | health-canada-dpd |
| — | Abiraterone Acetate | Health Canada CA | cancer not stated in this record | Marketed in Canada as MINT-ABIRATERONE (DIN 02571439) under ATC L02BX03 ABIRATERONE. Indications are not published in the Drug Product… | DIN02571439 | approved | health-canada-dpd |
| — | Azacitidine | Health Canada CA | cancer not stated in this record | Marketed in Canada as AZACITIDINE FOR INJECTION (DIN 02571102) under ATC L01BC07 AZACITIDINE. Indications are not published in the Drug… | DIN02571102 | approved | health-canada-dpd |
| — | Carboplatin | Health Canada CA | cancer not stated in this record | Marketed in Canada as CARBOPLATIN INJECTION BP (DIN 02570963) under ATC L01XA02 CARBOPLATIN. Indications are not published in the Drug… | DIN02570963 | approved | health-canada-dpd |
| — | Enzalutamide | Health Canada CA | cancer not stated in this record | Marketed in Canada as PMS-ENZALUTAMIDE (DIN 02570831) under ATC L02BB04 ENZALUTAMIDE. Indications are not published in the Drug Product… | DIN02570831 | approved | health-canada-dpd |